Low-dose lansoprazole provides greater relief of heartburn and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 3, 1999, Pages 413-419

  Jones, R ^a   Crouch, S L ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; LANSOPRAZOLE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYMPTOM; THORAX PAIN;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; GASTRIC ACID; HEARTBURN; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PAIN;

EID: 0033027842     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00455.x     Document Type: Article

References (9)

1. 1 Jones RH, Lydeard SE, Hobbs FDR, et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401-5.
2. 2 Jones R, Murfin D. Gastrointestinal problems in the community and in general practice. In: Jones R, ed. Gastrointestinal Problems in General Practice. Oxford: Oxford University Press, 1993.
3. 3 Axon ATR. Chronic dyspepsia: who needs endoscopy? Gastroenterology 1997; 112: 1376-80.
4. 4 Agreus L, Talley N. Challenges in managing dyspepsia in general practice. Br Med J 1997; 315: 1284-8.
5. 5 McLauchlan G, Crean GP, McColl KE. Effect of low-dose omeprazole on gastric acid secretion in duodenal ulcer patients. Aliment Pharmacol Ther 1988; 2: 263-8.
6. 6 Robinson M, Lanza F, Avner D, Haber M. Effective maintenance treatment of reflux oesophagitis with low-dose lansoprazole. A randomised double blind placebo controlled trial. Ann Int Med 1996; 124: 859-67.
7. 7 Gough AL, Long RG, Cooper BT, et al. Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis. Aliment Pharmacol Ther 1996; 10: 529-39.
8. 8 Jones RH, Baxter G. Lansoprazole 30mg daily versus ranitidine 150mg bd in the treatment of acid related dyspepsia in general practice. Aliment Pharmacol Ther 1997; 11: 541-6.
9. 9 Heading RC. Long-term management of gastro-oesophageal reflux disease. Scand J Gastroenterol 1995; 213(Suppl.): 25-30.